News Sentiment

RDY sentiment intelligence

Dr. Reddy’s Laboratories Ltd ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 22 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 13.29 Week of 19 Jun 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

89/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.1% over one week, -2.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Dr. Reddy’s (NYSE: RDY) schedules July 22 board meeting, shuts trading window

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 89/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend inactive -2.3% over four weeks
Fair value -6.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 21
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
ChartMill 3
MarketBeat 1
GuruFocus 1
Market source 1

Event Lens

What the news is about

Classified themes
Market update 18
Earnings 2
Capital return 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-22 of 22